RenovoRx Announces Presentation at Symposium on Clinical Interventional Oncology Highlighting TAMP™ for Targeted Treatment of Locally Advanced Pancreatic Cancer - RenovoRx ( NASDAQ:RNXT )
LOS ALTOS, Calif., Sept. 19, 2024 ( GLOBE NEWSWIRE ) -- RenovoRx, Inc. ( "RenovoRx" or the "Company" ) RNXT, a clinical-stage biopharmaceutical company developing novel precision oncology therapies based on a local drug-delivery platform, today announced that Ripal Gandhi, M.D., FSIR, FSVM will ...
| Ticker |
Sentiment |
Impact |
|
L
|
Neutral
|
5 %
|
|
META
|
Neutral
|
2 %
|
|
RNXT
|
Neutral
|
20 %
|
